First GLP-1 analog liraglutide: the result of clinical trails on efficacy
This review analytically considers the results of clinical trials on efficacy and safety and clinical perspectives of GLP-1 analog liraglutide
Enregistré dans:
Auteurs principaux: | Alexander Sergeevich Ametov, Lyudmila Leonidovna Kamynina |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fadfb6f4534043718b50e3d267ba37a6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
par: Alexander Sergeevich Ametov, et autres
Publié: (2011) -
The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
par: Marina Vladimirovna Shestakova
Publié: (2010) -
Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
par: Lyudmila Alexandrovna Ruyatkina, et autres
Publié: (2017) -
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
par: Campbell RK, et autres
Publié: (2010) -
Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
par: Vladimir Ivanovich Kudinov, et autres
Publié: (2011)